Analyst Reco. Medical Properties Trust, Inc.

Equities

MPW

US58463J3041

Real-time Estimate Cboe BZX Other stock markets 03:09:40 2024-05-16 pm EDT			5-day change	1st Jan Change
5.125 ^USD	-5.44%		+9.17%	+4.28%

06:56pm	Medical Properties Trust Receives Noncompliance Notice from NYSE Over Delay in Filing Quarterly Report	MT
May. 14	RBC Downgrades Medical Properties Trust to Sector Perform From Outperform, Price Target is $5 Amid Tenant-Related Concerns	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

RBC Downgrades Medical Properties Trust to Sector Perform From Outperform, Price Target is $5 Amid Tenant-Related Concerns	May. 14	MT
RBC Downgrades Medical Properties Trust to Sector Perform From Outperform, Price Target is $5	May. 14	MT
Deutsche Bank Upgrades Medical Properties Trust to Hold From Sell, Adjusts PT to $5 From $2	Apr. 17	MT
Truist Securities Raises Price Target on Medical Properties Trust to $4.50 From $4, Maintains Hold Rating	Apr. 08	MT
BNP Paribas Exane Upgrades Medical Properties Trust to Outperform From Neutral, Price Target is $6	Mar. 01	MT
RBC Cuts Price Target on Medical Properties Trust to $5 From $8 on Steward-Related Rent Disruption, Keeps Outperform, Speculative Risk	Feb. 20	MT
KeyBanc Downgrades Medical Properties Trust to Sector Weight From Overweight, Removes $15 Price Target Amid Uncertainty, Risks to Tenant Health	Jan. 05	MT
Mizuho Securities Adjusts Medical Properties Trust's Price Target to $7 From $9, Keeps Neutral Rating	Jan. 03	MT
RBC Cuts Price Target on Medical Properties Trust to $8 From $10, Keeps Outperform Rating	Nov. 28	MT
Stifel Downgrades Medical Properties Trust to Hold From Buy, Adjusts Price Target to $4.50 From $12	Nov. 10	MT
Wells Fargo Downgrades Medical Properties Trust to Underweight From Equalweight, Cuts Price Target to $4 From $7	23-10-16	MT
Mizuho Downgrades Medical Properties Trust to Neutral From Buy, Adjusts Price Target to $9 From $18	23-08-31	MT
Barclays Adjusts Price Target on Medical Properties Trust to $10 From $12, Maintains Overweight Rating	23-08-22	MT
JPMorgan Downgrades Medical Properties Trust to Underweight From Neutral, Adjusts Price Target to $7 From $9	23-08-21	MT
ANALYST RECOMMENDATIONS : Alphabet, AstraZeneca, FMC Corp, Target, Wise...	23-08-21
RBC Adds Speculative Risk Qualifier to Outperform Rating on Medical Properties Trust, Cuts PT to $10 From $12 After 'Disappointing' Q2 Results	23-08-14	MT
BofA Securities Downgrades Medical Properties Trust to Underperform From Neutral, Adjusts Price Target to $8 From $9	23-08-11	MT
Raymond James Downgrades Medical Properties Trust to Underperform From Strong Buy	23-08-11	MT
Truist Securities Adjusts Medical Properties Trust Price Target to $10 From $9, Maintains Hold Rating	23-06-23	MT
Wells Fargo Starts Medical Properties Trust at Equalweight With $9 Price Target	23-04-20	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Medical Properties Trust, Inc.

Equities

MPW

US58463J3041

Analyst Reco.

Filters